Compare

Iovance Biotherapeutics, Inc. vs Vericel Corp vs Adaptive Biotechnologies Corp vs REGENXBIO Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearIovance Biotherapeutics, Inc.Vericel CorpAdaptive Biotechnologies CorpREGENXBIO Inc.
Latest$263.50M
Ended 2025-12-31
$276.26M
Ended 2025-12-31
$276.98M
Ended 2025-12-31
$170.44M
Ended 2025-12-31
1 year earlier$164.07M
Ended 2024-12-31
$237.22M
Ended 2024-12-31
$178.96M
Ended 2024-12-31
$83.33M
Ended 2024-12-31
2 years earlier$1.19M
Ended 2023-12-31
$197.52M
Ended 2023-12-31
$170.28M
Ended 2023-12-31
$90.24M
Ended 2023-12-31
3 years earliern/a$163.70M
Ended 2022-12-31
$185.31M
Ended 2022-12-31
$112.72M
Ended 2022-12-31
4 years earliern/a$153.07M
Ended 2021-12-31
$154.34M
Ended 2021-12-31
$470.35M
Ended 2021-12-31